Lansoprazole potentiates vecuronium paralysis.
J Indian Med Assoc
;
1997 Jul; 95(7): 422-3
Article
Dans Anglais
| IMSEAR
| ID: sea-103340
ABSTRACT
The effect of lansoprazole, a newer second generation proton pump inhibitor, on vecuronium induced muscle paralysis was evaluated. Fifty adult patients comprising grade I (normal healthy patient) and grade II (patient with a mild systemic disease) as classified by the American Society of Anesthesiologists were randomly allocated into two different groups each consisting of 25 patients. Group I (control) did not receive lansoprazole and group II (study) received 30 mg lansoprazole in the night before operation. There was no statistically significant difference (p > 0.05) in the time required for complete paralysis between group I (215.7 +/- 15.19 seconds) and group II (197.5 +/- 14.13 seconds). However, the duration of paralysis was significantly different (p < 0.05) between group I (32.7 +/- 8.7 minutes) and group II (43.9 +/- 9.3 minutes). It was concluded that there is a potential for interactions and one should carefully and closely monitor the patients to prevent prolonged paralysis in patients receiving lansoprazole, as a pre-anaesthetic medication.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Prémédication anesthésique
/
Oméprazole
/
Vécuronium
/
Femelle
/
Humains
/
Mâle
/
Cholécystectomie
/
Pompes à protons
/
Curarisants non dépolarisants
/
Adulte
Type d'étude:
Essai clinique contrôlé
langue:
Anglais
Texte intégral:
J Indian Med Assoc
Année:
1997
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS